Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineDaniel E. Neafsey, Dyann F. Wirth, Carsten Russ et al.|New England Journal of Medicine|2015Cited by 451
Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trialLucas Otieno, Mary J. Hamel|The Lancet Infectious Diseases|2016Cited by 34
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Wally R. Smith, Lucas Otieno et al.|The Lancet Haematology|2024Cited by 25